Saredutant

Saredutant is a potent and selective NK2 (neurokinin 2) receptor antagonist investigated for anxiolytic and antidepressant properties. Mediocon Inc supplies pharmaceutical-grade Saredutant conforming to IP / BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.

Saredutant blocks the tachykinin NK2 receptor which is involved in the modulation of mood and stress responses. It has been studied in clinical trials for major depressive disorder.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Anxiety and depression research
• NK2 receptor pharmacology studies
• Neuroscience drug development
• CNS preclinical R&D

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings

Parameter	Specification
Assay	NLT 98.0%
Loss on Drying	NMT 0.5%
Heavy Metals	NMT 20 ppm
Residue on Ignition	NMT 0.1%
Microbial Limits	Complies with pharmacopoeia
Identification	IR, HPLC Compliant
Mfg Date	MAR 2025
Exp Date	FEB 2030
Packing	25 kg HDPE drums / as per requirement